Andreas Kluge
Founder at TELIX PHARMACEUTICALS LIMITED
Net worth: 222 M $ as of 2024-04-29
Andreas Kluge active positions
| Companies | Position | Start | End |
|---|---|---|---|
| TELIX PHARMACEUTICALS LIMITED | Director/Board Member | 2017-01-02 | - |
| Founder | 2015-10-31 | - | |
| Chief Tech/Sci/R&D Officer | 2017-01-02 | 2020-06-01 | |
Therapeia GmbH & Co. Kg
 Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Chief Executive Officer | 2006-12-31 | - |
| Founder | 2006-12-31 | - | |
| Chief Tech/Sci/R&D Officer | 2006-12-31 | - | |
| ABX-CRO advanced pharmaceutical services | Chief Tech/Sci/R&D Officer | 2002-07-31 | - |
| Founder | 2002-07-31 | - |
Career history of Andreas Kluge
Former positions of Andreas Kluge
| Companies | Position | Start | End |
|---|---|---|---|
ABX advanced biochemical compounds GmbH
 ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Chief Executive Officer | 1996-08-31 | 2002-06-30 |
| Founder | 1996-08-31 | 2002-06-30 |
Training of Andreas Kluge
| Freie Universität Berlin | Doctorate Degree |
Statistics
International
| Germany | 5 |
| Australia | 2 |
Operational
| Founder | 4 |
| Chief Tech/Sci/R&D Officer | 3 |
| Chief Executive Officer | 2 |
Sectoral
| Health Technology | 3 |
| Consumer Services | 2 |
| Process Industries | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
| Listed companies | 1 |
|---|---|
| TELIX PHARMACEUTICALS LIMITED | Health Technology |
| Private companies | 3 |
|---|---|
ABX advanced biochemical compounds GmbH
ABX advanced biochemical compounds GmbH Chemicals: SpecialtyProcess Industries Part of Otsuka Holdings Co., Ltd., ABX advanced biochemical compounds GmbH is a German company that manufactures chemicals for nuclear medicine applications. The company is based in Radeburg, Germany. The company was founded by Andreas Kluge. Andreas Kluge has been the CEO since incorporation. ABX advanced biochemical compounds was acquired by Cambridge Isotope Laboratories, Inc. on September 20, 2006. | Process Industries |
Therapeia GmbH & Co. Kg
Therapeia GmbH & Co. Kg Pharmaceuticals: MajorHealth Technology Therapeia GmbH & Co. Kg provides diagnostic and therapeutic radiopharmaceuticals. The firm offers treatment for brain cancer. The company was founded by Andreas Kluge in 2007 and is headquartered in Dresden, Germany. | Health Technology |
| ABX-CRO advanced pharmaceutical services |
- Stock Market
- Insiders
- Andreas Kluge
- Experience
